MOKAN Wealth Management Inc.

Position in ABBV — AbbVie Inc.

CIK 2053727 OVERLAND PARK, KS

Position in ABBV

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$5,997,839

+$1,829,209 QoQ

Shares Held

23,835

+24.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

3.12%

of 13F equity value

Holder Rank

#1,204

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 12% None 88%

Healthcare · as of Jun 30, 2026

MOKAN Wealth Management Inc. holds $20,473,093 across 6 Drug Manufacturers - General names. ABBV ranks #2 (29.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	48,990	$6,295,215
2	ABBV	AbbVie Inc. This page	23,835	$5,997,839
3	LLY	ELI LILLY & Co	4,208	$5,047,201
4	JNJ	Johnson & Johnson	5,872	$1,491,311
5	GILD	Gilead Sciences, Inc.	10,399	$1,313,809
6	AMGN	Amgen Inc	905	$327,718

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,997,839	23,835	+24.4%	Shares	Sole	2026-07-28
2026-03-31	$4,168,630	19,167	-5.7%	Shares	Sole	2026-05-01
2025-12-31	$4,644,973	20,329	+11.7%	Shares	Sole	2026-01-26
2025-09-30	$4,212,870	18,195	-0.6%	Shares	Sole	2025-10-30
2025-06-30	$3,396,289	18,297	+21.5%	Shares	Sole	2025-07-25
2025-03-31	$3,155,580	15,061	-6.1%	Shares	Sole	2025-04-23
2024-12-31	$2,849,241	16,034	—	Shares	Sole	2025-01-30
No filing history on record for this holder in this stock.